Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583413 · ClinicalTrials.gov registry record · NA
CDC Prevention Epicenters Wake Up and Breathe Collaborative
A NA study, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 3,342
- Enrollment target
NCT01583413 is a NA study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 3,342 participants.
The verdict
NCT01583413, a NA study, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,342 participants
- Enrollment target
Study Summary
Ventilator-associated pneumonia (VAP) is a common complication of mechanical ventilation associated with significant morbidity, including prolongation of mechanical ventilation and increased ICU and hospital length-of-stay. Numerous strategies have been proposed to decrease the occurrence of VAP among ventilated patients. Most notably, optimizing the use of daily sedative interruptions and daily spontaneous breathing trials can improve sedative management, decrease ventilator time, improve outcomes for mechanically ventilated patients,and possibly decrease VAP.Combining daily sedative interruption with daily spontaneous breathing trials confers additive improvement in ventilator days, intensive care days, and possibly mortality compared to daily spontaneous breathing trials alone. The primary aim of this study is to determine the impact of an opt-out protocol for paired daily sedative interruptions and spontaneous breathing trials on VAP rates using a new streamlined VAP definition. The investigators will evaluate the responsiveness of CDC's proposed new surveillance definitions for ventilator-associated events to this quality improvement initiative. The study will be nested within the Epicenters Streamlined versus Conventional VAP Surveillance Study. Nine of the 18 hospitals in the larger study will be participating in this intervention arm.
Interventions
- PROCEDURE Daily SAT & SBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,342 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01583413
The ClinicalTrials.gov registry entry for NCT01583413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Daily SAT & SBT is the first listed.
NCT01583413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01583413 about?
NCT01583413 is a clinical study titled "CDC Prevention Epicenters Wake Up and Breathe Collaborative". Ventilator-associated pneumonia (VAP) is a common complication of mechanical ventilation associated with significant morbidity, including prolongation of mechanical ventilation and increased ICU and hospital length-of-stay. Numerous strategies have been proposed to decrease the occurrence of VAP amo...
What is the current status of trial NCT01583413?
This trial is currently completed. It is a NA study. The enrollment target is 3,342 participants. The study started on 2012-05. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01583413?
The interventions under investigation include: Daily SAT & SBT (PROCEDURE).
Who is sponsoring clinical trial NCT01583413?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.